Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women

[1] Cauley JA(2014)Geographic and ethnic disparities in osteoporotic fractures Nat Rev Endocrinol 10 338-351

[2] Chalhoub D(2013)Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF Osteoporos Int 24 2763-2764

[3] Kassem AM(2017)Worldwide prevalence and incidence of osteoporotic vertebral fractures Osteoporos Int 28 1531-1542

[4] Fuleihan Gel H(2017)Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up Osteoporos Int 28 853-862

[5] Kanis JA(2018)Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US Preventive Services Task Force JAMA 319 2532-2551

[6] Adachi JD(2001)New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures Spine 26 1511-1515

[7] Cooper C(2016)Zoledronic acid (Reclast((R)), Aclasta((R))): a review in osteoporosis Drugs 76 1683-1697

[8] Clark P(2010)The role of zoledronic acid in the management of osteoporosis Clin Rheumatol 29 1079-1084

[9] Cummings SR(2000)Clinical use of biochemical markers of bone remodeling: current status and future directions Osteoporos Int 11 467-480

[10] Diaz-Curiel M(2014)Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data Spine 39 318-326

[1] Cauley JA(2014)Geographic and ethnic disparities in osteoporotic fractures Nat Rev Endocrinol 10 338-351

[2] Chalhoub D(2013)Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF Osteoporos Int 24 2763-2764

[3] Kassem AM(2017)Worldwide prevalence and incidence of osteoporotic vertebral fractures Osteoporos Int 28 1531-1542

[4] Fuleihan Gel H(2017)Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up Osteoporos Int 28 853-862

[5] Kanis JA(2018)Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US Preventive Services Task Force JAMA 319 2532-2551

[6] Adachi JD(2001)New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures Spine 26 1511-1515

[7] Cooper C(2016)Zoledronic acid (Reclast((R)), Aclasta((R))): a review in osteoporosis Drugs 76 1683-1697

[8] Clark P(2010)The role of zoledronic acid in the management of osteoporosis Clin Rheumatol 29 1079-1084

[9] Cummings SR(2000)Clinical use of biochemical markers of bone remodeling: current status and future directions Osteoporos Int 11 467-480

[10] Diaz-Curiel M(2014)Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data Spine 39 318-326